Ledger.Open graph →
SEC Form D · filed January 5, 2024

Elicio Therapeutics, Inc

Offering
$7.0M
Sold
$7.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Boston, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (33)

Julian Adams · Boston, MADirectorChristopher Haqq · Boston, MAExecPeter Demuth · Boston, MAExecBrian Piekos · Boston, MAExecAllen Nissenson · Boston, MADirectorCarol Ashe · Boston, MADirectorJay Venkatesan · Boston, MADirectorRobert Ruffolo · Boston, MADirectorRobert Connelly · Boston, MAExec · DirectorKaren Wilson · Boston, MADirectorYekaterina Chudnovsky · Boston, MADirectorBrian Piekos · Boston, MAExecPeter Demuth · Boston, MAExecChristopher Haqq · Boston, MAExecRobert Ruffolo · Boston, MADirectorJay Venkatesan · Boston, MADirectorJulian Adams · Boston, MADirectorRobert Connelly · Boston, MAExec · DirectorKaren Wilson · Boston, MADirectorAllen Nissenson · Boston, MADirectorCarol Ashe · Boston, MADirectorYekaterina Chudnovsky · Boston, MADirectorMatthew Maletta · Malvern, PADirectorJohn S. Gault · Austin, TXDirectorPaul Haycock · Dublin, IrelandExecDarin Bifani · Dublin, IrelandDirectorJuan Linietsky · Dublin, IrelandDirectorMatthew Koester · Madison, WIExecThomas Shivers · Dover, DEExec · DirectorBarret Ayres · Dover, DEDirectorShelly Kurtz · Omaha, NEDirectorBen Jackson · Omaha, NEExecDusty Davidson · Omaha, NEDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗